Daljit Singh Aurora
Vermogen: 64 838 $ op 31-08-2026
Vermogen: 64 838 $ op 31-08-2026
Daljit Singh Aurora is currently Chief Operating & Development Officer at Neumora Therapeutics, Inc. since 2025.
Former positions include Chief Scientific Affairs Officer at Dermira, Inc. from 2019 to 2021, Vice President-Medical Affairs at Neurocrine Biosciences, Inc. from 2015 to 2016, Vice President-Scientific Affairs at Merck Research Laboratories Massachusetts LLC from 2014 to 2015, and VP-Worldwide Compliance & Business Ethics at Amgen, Inc. from 2013 to 2014.
Education includes undergraduate studies at The University of Texas at Austin and a doctorate from The University of Texas Health Science Center at Houston.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 21-08-2026 | 48.750 ( 0,03% ) | 64 838 $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Operationeel Directeur | 14-02-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
| DERMIRA, INC. | Compliance Officer | 01-11-2019 |
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 01-07-2016 |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Corporate Officer/Principal | 01-04-2015 |
| AMGEN INC. | Corporate Officer/Principal | 01-09-2014 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 7 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Dermira, Inc.
Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
The University of Texas Health Science Center at Houston
The University of Texas Health Science Center at Houston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neumora Therapeutics, Inc.
Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau